Transitioning V.a.c. Therapy Into Home Care; V.a.c.ulta™ Therapy System Contraindications; Additional Contraindications Specific To V.a.c. Veraflo™ Therapy - GD V.A.C.ULTA Manual Del Usario

trANsitioNiNg V.A.C.
the V.A.C.Ulta™ therapy system is not intended for home use.
if there is a need to continue V.A.C.
transitions home, consider using other KCi therapy systems
approved for the post-acute care environment. refer to the
safety information included with those devices for important
information.
V.A.C.UltA™ therAPy system CoNtrAiNdiCAtioNs
•
Do not place foam dressings of the V.A.C.Ulta™ Therapy System (including both V.A.C.
Therapy and V.A.C. VeraFlo™ Therapy Dressings) directly in contact with exposed blood
vessels, anastomotic sites, organs or nerves.
Note: Refer to Warnings section for additional information concerning Bleeding.
•
V.A.C. Therapy and V.A.C. VeraFlo™ Therapy are contraindicated for patients with:
®
•
Malignancy in the wound
•
Untreated osteomyelitis
Note: Refer to Warnings section for Osteomyelitis information.
•
Non-enteric and unexplored fistulas
•
Necrotic tissue with eschar present
Note: After debridement of necrotic tissue and complete removal of eschar, V.A.C.
Therapy may be used.
•
Sensitivity to silver (V.A.C. GranuFoam Silver
AdditioNAl CoNtrAiNdiCAtioNs sPeCifiC to V.A.C. VerAflo™
therAPy
•
Do not use V.A.C.
solutions that are alcohol-based or contain alcohol.
•
Do not deliver fluids to the thoracic or abdominal cavity due to the potential
risk to alter core body temperature and the potential for fluid retention within
the cavity.
•
Do not use V.A.C. VeraFlo™ Therapy unless the wound has been throughly
explored due to the potential for inadvertent instillation of topical wound
solutions to adjacent body cavities.
*Not available in the United States. Brand name referenced is not a trademark of
KCI, its affiliates, or licensors.
therAPy iNto home CAre
®
®
®
Dressings with Octenisept
®
5
therapy when a patient
Dressing only)
*, hydrogen peroxide or
®
®
®